
Sign up to save your podcasts
Or


Dr. Nagourney discusses how drugs gain FDA approval and go on to clinical application but fail to realize their full potential as rigid guidelines undermine the intelligent use of active treatments and combinations.
Cancer patients today confront a dizzying array of treatment options but current “protocol-driven” therapies have had little impact on survival. Patients need actionable information and Dr. Nagourney provides just that.
From the publisher's feed